{"id":"https://openalex.org/W197629138","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e13101","title":"Clinical outcomes and prognostic factors of hepatic arterial infusion (HAI) chemotherapy combination regimens in 202 patients with advanced cancer metastatic to the liver: The phase I program M. D. Anderson Cancer Center experience.","display_name":"Clinical outcomes and prognostic factors of hepatic arterial infusion (HAI) chemotherapy combination regimens in 202 patients with advanced cancer metastatic to the liver: The phase I program M. D. Anderson Cancer Center experience.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W197629138","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e13101","mag":"197629138"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.e13101","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e13101","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.e13101","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051178184","display_name":"C. Vaklavas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Vaklavas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044840107","display_name":"Apostolia Maria Tsimberidou","orcid":"https://orcid.org/0000-0003-2713-233X","observed_orcids":["https://orcid.org/0000-0003-2713-233X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. M. Tsimberidou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Wen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043214777","display_name":"Shuang Fu","orcid":"https://orcid.org/0000-0002-8804-4440","observed_orcids":["https://orcid.org/0000-0002-8804-4440"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Fu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. S. Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113709286","display_name":"J. J. Wheler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Wheler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014322192","display_name":"A. Naing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Naing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112024952","display_name":"Cynthia Uehara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Uehara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035371911","display_name":"Robert A. Wolff","orcid":"https://orcid.org/0000-0002-6614-1610","observed_orcids":["https://orcid.org/0000-0002-6614-1610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. A. Wolff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Kurzrock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"e13101","last_page":"e13101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.03500000014901161,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatic-arterial-infusion-chemotherapy","display_name":"hepatic arterial infusion chemotherapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.8560000061988831},{"id":"https://openalex.org/keywords/liposomal-doxorubicin","display_name":"liposomal doxorubicin","score":0.8479999899864197},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.878000020980835},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8709999918937683},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8640000224113464},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7689999938011169},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8220000267028809},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5070000290870667},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.734000027179718},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9653310775756836},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6871188879013062},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6322205066680908},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.560017466545105},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5443857908248901},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4927056133747101},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48816972970962524},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4846799671649933},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.4248659014701843},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37163135409355164},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33887237310409546}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.e13101","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e13101","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.e13101","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W162494990","https://openalex.org/W2098000671","https://openalex.org/W2242406387","https://openalex.org/W83866096","https://openalex.org/W2170653283","https://openalex.org/W3010672578","https://openalex.org/W2271595497","https://openalex.org/W2278136291","https://openalex.org/W2139000953","https://openalex.org/W2889757285"],"abstract_inverted_index":{"e13101":[0],"Background:":[1],"To":[2],"assess":[3],"the":[4,24,139,175,198,216,238,257],"clinical":[5],"outcomes":[6],"in":[7,321],"patients":[8,322],"(pts)":[9],"with":[10,76,154,187,191,230,234,323],"advanced":[11,324],"cancer":[12,189,232,325],"and":[13,30,70,108,138,174,202,206,242,246,256,281,307,326],"hepatic":[14],"involvement":[15],"treated":[16,75,190,233],"on":[17],"HAI":[18,77,82,87,90,93,192,235,315],"protocols.":[19],"Methods:":[20],"Patients":[21,73],"referred":[22],"to":[23],"phase":[25],"I":[26],"program":[27],"between":[28],"4/02":[29],"9/09":[31],"were":[32,39,57,74,204,244,275],"analyzed.":[33],"Results:":[34],"Overall,":[35],"202":[36],"consecutive":[37],"pts":[38,125,153,186,229],"identified":[40],"(median":[41],"age,":[42],"57":[43],"yrs;":[44],"46%":[45],"men,":[46],"54%":[47],"women;":[48],"median":[49,121,130,140,176,217,258],"number":[50],"of":[51,123,200,240,284],"prior":[52],"therapies,":[53],"4).":[54],"Cancer":[55],"types":[56],"colorectal":[58,188],"45%,":[59],"breast":[60,231],"17%,":[61],"melanoma":[62],"8%,":[63],"hepatocellular":[64,155],"5%,":[65],"ovarian":[66],"3%,":[67,69],"cholangiocarcinoma":[68],"others":[71],"19%.":[72],"oxaliplatin+IV":[78],"5-FU,":[79],"n=":[80],"101;":[81],"cisplatin\u00b1IV":[83],"liposomal":[84],"doxorubicin,":[85],"n=50;":[86],"paclitaxel,":[88],"n=35;":[89],"irinotecan,":[91],"n=11;":[92],"other,":[94],"n=5.":[95],"Of":[96],"188":[97],"evaluable":[98],"pts,":[99,118,172,214,254],"13":[100],"(7%)":[101,160],"had":[102,162],"a":[103],"PR":[104,201,241],"(by":[105],"RECIST":[106],"1.0);":[107],"82":[109],"(44%)":[110],"stable":[111],"disease":[112],"(SD;":[113],"\u2265":[114,168,210,250],"4":[115,169,211,251],"months,":[116,170,212,252],"44":[117],"22%).":[119],"The":[120,129],"follow-up":[122],"surviving":[124],"was":[126,132,143,178,219,260],"6.9":[127],"months.":[128],"survival":[131,142,177,218,259,274],"7.2":[133,220],"months":[134,145,180,221,262],"(95%":[135,146,222,263],"CI:":[136,147,223,264],"6.0\u20138.4);":[137],"progression-free":[141],"2.5":[144],"2.0":[148],"\u2013":[149,225],"3.8).":[150],"In":[151,184,227,268],"15":[152],"carcinoma":[156],"or":[157,194,332,336],"cholangiocarcinoma,":[158],"1":[159],"patient":[161],"PR,":[163],"11":[164],"(73%)":[165],"SD":[166,203,243],"(SD":[167,209,249],"5":[171],"33%);":[173],"14.8":[179],"(CI,":[181],"10.3-":[182],"39.0+).":[183],"68":[185],"oxaliplatin":[193],"irinotecan":[195],"combination":[196,316],"therapy,":[197,237],"rates":[199,239],"7.5%":[205],"55.2%,":[207],"respectively":[208],"23":[213],"34%);":[215],"5.4":[224],"9.2).":[226],"31":[228],"cisplatin-based":[236],"11%":[245],"30%,":[247],"respectively,":[248],"7":[253],"23%);":[255],"14.2":[261],"6.5":[265],"-":[266],"39+).":[267],"multivariate":[269],"analysis":[270],"factors":[271],"predicting":[272],"longer":[273],"female":[276],"gender":[277],"(p":[278],"=":[279,295,305,312],"0.007);":[280],"normal":[282],"levels":[283],"albumin":[285],"(\u22653.4":[286],"g/dL;":[287,303],"p":[288,294,304,311],"<":[289],"0.001),":[290],"bilirubin":[291],"(\u22641":[292],"mg/dL;":[293],"0.004),":[296],"LDH":[297],"(\u2264618":[298],"IU/L;":[299,310],"p=0.008),":[300],"hemoglobin":[301],"(\u226511":[302],"0.02),":[306],"AST":[308],"(<46":[309],"0.049).":[313],"Conclusions:":[314],"therapies":[317],"have":[318],"antitumor":[319],"activity":[320],"liver":[327],"involvement.":[328],"Author":[329],"Disclosure":[330],"Employment":[331],"Leadership":[333],"Position":[334],"Consultant":[335],"Advisory":[337],"Role":[338],"Stock":[339],"Ownership":[340],"Honoraria":[341],"Research":[342],"Funding":[343],"Expert":[344],"Testimony":[345],"Other":[346],"Remuneration":[347],"AstraZeneca,":[348,356,379],"Centocor,":[349,384],"Johnson":[350,367],"&":[351,368],"Johnson,":[352,369],"Maxygen,":[353,370],"Merck":[354],"Amgen,":[355,376],"Center":[357],"for":[358],"Biomedical":[359],"Continuing":[360],"Education,":[361],"Enzon,":[362,390],"Genentech,":[363,392],"IDSC,":[364],"ImClone":[365],"Systems,":[366],"Merck,":[371,397],"Pharmion,":[372,406],"Roche":[373],"Abraxis":[374],"BioScience,":[375],"AmpliMed,":[377],"Antigenics,":[378],"Bayer,":[380],"Bristol-Myers":[381],"Squibb,":[382],"Callisto,":[383],"Concordia,":[385],"Curagen,":[386],"Eisai,":[387],"Eli":[388],"Lilly,":[389,396],"Exelixis,":[391],"GlaxoSmithKline,":[393],"Globomax,":[394],"Kinex,":[395],"Metastatix,":[398],"MGI":[399],"Pharma,":[400],"Myriad,":[401],"Nereus,":[402],"Novartis,":[403],"Pfizer,":[404],"Pharmacyclics,":[405],"Phoenix":[407],"Biotech,":[408],"Reata,":[409],"Roche,":[410],"Taiho":[411],"Pharmaceutical,":[412],"Vioquest,":[413],"Ziopharm":[414]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2016-06-24T00:00:00"}